Continuous monitoring and treatment of chronic conditions is fast becoming a health and fiscal priority worldwide, although patient adherence levels remain low in many instances. At Tyndall National Institute, our team is developing minimally invasive Micro Transdermal Interface Platforms (MicroTIPs) to address this need. These intelligent, patch-like systems will ultimately be capable of independently diagnosing physiological conditions and autonomously delivering relevant therapeutics, while simultaneously relaying information to clinical personnel and mHealth platforms. This talk outlies examples of progress in key aspects of those platforms, such as microneedle technologies for electrochemical diagnostics, interstitial fluid sampling, biopotential monitoring, and embedded sensors for closed-loop drug delivery.
Dr. Conor O’Mahony is a Principal Scientist with the Tyndall National Institute, and an Adjunct Professor at Chongqing Technology and Business University, China. His team is focussed on the development of Micro Transdermal Interface Platforms (MicroTIPs) – high-value, wearable systems that combine transdermal delivery, diagnostics, self-awareness and communications capabilities. For use in theranostics and advanced woundcare, these ‘smart patches’ interact with the outermost skin layers in a minimally invasive manner, and will blur the lines between implantable medical devices and electronic wearables. A Senior Member of the IEEE, he has published over sixty peer-reviewed journal papers, and given numerous conference presentations worldwide.